The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
The Joint Corp.NASDAQ: JYNT
EPS (Diluted) · Q1 FY2026 · quarter ended Mar 2026
EPS (Diluted) grows, but more slowly than its trailing trend
Q1 FY2026 EPS (Diluted) of $0.09 rose 74.5% year over year, behind the +138.3% change in trailing-twelve-month EPS (Diluted). Sequentially, it rose 34.7% from the prior quarter. Over 3 fiscal years it compounded at +63.7% a year.
Context
- EPS (Diluted) increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 1 analysts of $0.24 (+28.1%) for the fiscal year ending Dec 2026, a slowdown from the +148.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $0.09+34.7% QoQ
- Last fiscal yearDec 2025
- $0.19+148.7% YoY
- LTMMar 2026
- $0.22+138.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +74.5% | +665.0% | +590.6 pp |
| 1 year | +148.7% | +28.1% | -120.6 pp |
| 3-year CAGR | +63.7% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 0.19 USD
- Year-over-year change
- +148.7%
- 4-year CAGR
- -18.9%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0.19 | +148.7% |
| FY2024 | 2024-12-31 | (0.39) | +40.9% |
| FY2023 | 2023-12-31 | (0.66) | -1624.2% |
| FY2022 | 2022-12-31 | 0.04 | -90.2% |
| FY2021 | 2021-12-31 | 0.44 | — |
EPS (Diluted) vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's LTM Mar 2026 EPS (Diluted) of $0.22 is the 2nd highest of the 11 companies compared; the peer median is -$0.5.
- Its year-over-year change of +138.3% is the 2nd highest of 11, against a peer median of +61.1%.
- Over three fiscal years its annual growth of +63.7% compares with a peer median of +66.6%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $0.45 | -26.7% | +66.6% | |
| LTM Mar 2026 | $0.22 | +138.3% | +63.7% | |
| LTM Mar 2026 | $0.11 | +147.8% | — | |
| LTM Mar 2026 | -$0.22 | +60.9% | — | |
| LTM Mar 2026 | -$0.26 | +64.6% | — | |
| LTM Mar 2026 | -$0.47 | +61.2% | — | |
| LTM Mar 2026 | -$0.54 | +66.9% | — | |
| LTM Mar 2026 | -$0.65 | +30.9% | — | |
| LTM Mar 2026 | -$1.11 | -7.8% | — | |
| LTM Mar 2026 | -$1.91 | -16508.7% | — | |
| LTM Mar 2026 | -$8.2 | +99.5% | — | |
| Peer median (excluding JYNT) | -$0.5 | +61.1% | +66.6% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 80.01M | 101.25M | 46.98M | 52.16M | 54.9M |
| Cost of Revenue | 7.67M | 9.17M | 10.48M | 11.52M | 11.23M |
| Gross Profit | 72.35M | 92.08M | 36.5M | 40.65M | 43.67M |
| Gross Margin | 90.4% | 90.9% | 77.7% | 77.9% | 79.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 62.27M | 81.95M | 34.92M | 41.1M | 42.93M |
| Operating Expenses | 66.22M | 91.25M | 36.18M | 42.54M | 44.58M |
| Depreciation & Amortization | 3.92M | 6.65M | 8.58M | 4.72M | 1.71M |
| EBITDA | 10.07M | 7.89M | 8.88M | 2.9M | 1.48M |
| EBITDA Margin | 12.6% | 7.8% | 18.9% | 5.6% | 2.7% |
| Operating Income | 6.13M | 828.25K | 318.3K | (1.89M) | (905.48K) |
| Operating Margin | 7.7% | 0.8% | 0.7% | -3.6% | -1.6% |
| Interest Income | 0 | 133.1K | 0 | 280.29K | 0 |
| Interest Expense | 0 | 953.53K | 64.29K | 0 | 0 |
| Other Income / Expenses | (69.88K) | (133.1K) | (64.29K) | 280.29K | 675.97K |
| Income Before Tax | 6.06M | 695.15K | 254.01K | (1.61M) | (229.5K) |
| Pre-Tax Margin | 7.6% | 0.7% | 0.5% | -3.1% | -0.4% |
| Income Tax Expense | (1.51M) | 68.45K | 11.02M | 5.61K | 38.65K |
| Net Income | 7.57M | 626.71K | (9.75M) | (5.8M) | 2.91M |
| Net Margin | 9.5% | 0.6% | -20.8% | -11.1% | 5.3% |
| EPS (Basic) | 0.46 | 0.04 | (0.66) | (0.39) | 0.19 |
| EPS (Diluted) | 0.44 | 0.04 | (0.66) | (0.39) | 0.19 |
| Weighted Avg Shares | 14.32M | 14.49M | 14.69M | 14.92M | 15.13M |
| Weighted Avg Shares (Diluted) | 14.94M | 14.87M | 14.69M | 15.15M | 15.13M |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.